Participants 70 194 6
women with angiographically verified coronary artery disease: results from the estrogen in women with atherosclerosis study.
Participants 304 338 4
women with coronary artery disease
Participants 340 781 8
In a single-center, open, randomized study, 118 postmenopausal women with angiographically verified coronary artery disease were randomized to hormone replacement therapy, given as long-cycle transdermal 17-beta-estradiol (50 microg/24 hour) for 3 months with sequential medroxy-progesterone acetate for 14 days, or to a control group receiving no therapy. Hemostatic parameters were measured at baseline and after 3 and 12 months of therapy
